🌎 A new webpage for contemporary times. 🔗 Go check out our new website, https://www.c4c.cl, which features our disclosed technologies and their progress, clinical trials, patents, and more! Available both in English and Spanish! 👇How do you like it? Comment below!
Cells for Cells
Investigación biotecnológica
Las Condes, Región Metropolitana de Santiago 4758 seguidores
Experts in Cell Therapy
Sobre nosotros
Cells for Cells S.A. is a Chilean-based biotech company dedicated to the research, development and commercialization of cell therapies and tissue-engineered revolutionary solutions. The company counts with a broad portfolio of more than 10 technologies including Cellistem®OA, a clinical trial-supported cell therapy for the treatment of knee osteoarthritis, Inkure®, a bioink for the treatment of focal chondral lesions, Oxium®Exo, a culture media for the production of exosomes, and Veintis™, a bioinspired tissue-engineered vascular graft for vascular bypass applications, among others. Cells for Cells S.A. (a.k.a. C4C) is a spin off from Universidad de los Andes, Chile, and was founded in 2010.
- Sitio web
-
http://c4c.cl/
Enlace externo para Cells for Cells
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- De 11 a 50 empleados
- Sede
- Las Condes, Región Metropolitana de Santiago
- Tipo
- Asociación
- Fundación
- 2010
- Especialidades
- Regenerative Medicine, Biotechnology, Cell Therapy, Tissue Engineering, Bioengineering, Biomaterials, Exosomes y Orthobiologics
Ubicaciones
-
Principal
Avenida Isidora Goyenechea 2939
Piso 11
Las Condes, Región Metropolitana de Santiago 7550000, CL
Empleados en Cells for Cells
-
Matías Vial Valdés
Director Ejecutivo Cells for Cells | Miembro del Directorio: IPlacex, HubTec, ProSalud Chile, IMPACT | Consultor Estratégico TEC Monterrey | Mentor…
-
Daniel Meza
Application Specialist
-
Ana Maria Vega Letter
Postdoctoral Researcher
-
Diego Alejandro Castro Pulgar
Project Manager en Cells for Cells S.A.
Actualizaciones
-
Get ready to dive into the investor playbook! Maximiliano Kunze Küllmer and his colleagues from the ISCT, International Society for Cell & Gene Therapy's “i to i” program provide us with a framework to understand which factors regarding Cell and Gene therapy product development would have the greatest influence on the willingness to invest.
I am excited to share with you the publication of our ISCT, International Society for Cell & Gene Therapy Business Development & Finance Committee paper, "Cell and Gene Therapy Investment: Evolution and Future Outlook on Investor Perspectives," in which I am the first author. The paper provides key insights into how investors view CGT opportunities, where they typically deploy capital, the size of their funds, and what they worry most about, among other things. Kudos to Patrick Rivers, Asthika Goonewardene, Sven Kili, and Stefanos Theoharis for their top-notch contributions. Share this publication by using the link below. 👇 https://lnkd.in/eKjsUhWk
Please wait
sciencedirect.com
-
Sometimes less is more, says new clinical trial published by Cells for Cells and IMPACT Center of Interventional Medicine for Precision and Advanced Cellular Therapy and Clínica Universidad de los Andes, teams. 🗝 findings: . Low and medium doses of Cellistem®OA , a MSC-based therapy, were more effective in OA patients. . Intra-articular infusion of a high dose of Cellistem®OA, induces local swelling associated with inflammation. Maroun khoury Patricia Luz Francisco Espinoza V M. Ignacia Cádiz #cellandgenetherapy #osteoarthritis #stemcelltherapy https://lnkd.in/dUs5YSUy
A Phase I Dose-Escalation Clinical Trial to Assess the Safety and Efficacy of Umbilical Cord-Derived Mesenchymal Stromal Cells in Knee Osteoarthritis
academic.oup.com
-
The orthoregeneration network, ON Foundation launches this year, its inaugural Translational Fellowship program in Latin America. The tour included a visit to our facilities at Cells for Cells, IMPACT Center of Interventional Medicine for Precision and Advanced Cellular Therapy and Clínica Universidad de los Andes. During the visit, we shared with the selected fellows, foundation members and director, our insights in the realm of #Orthoregeneration ON is an independent international foundation in the field of orthopedic tissue regeneration that drives the discovery and understanding of innovative therapeutic solutions for patient well-being. Kay Horsch Tiago Lazzaretti Fernandes Camila Cohen Kaleka Maroun khoury Juan Pablo Acevedo Cox #orthobiologics #regenerativemedicine